Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Drug Metabolism Letters|February 4, 2012
Loxapine P-glycoprotein interactions in vitroAndrea Reed, Keith Huie, Elke S Perloff, et al.European Journal of Clinical Pharmacology|September 17, 2004
Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteersAndreas Johne, Elke S Perloff, Steffen Bauer, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 15, 2005
Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitroElke S Perloff, Su X Duan, Paul R Skolnik, et al.British Journal of Clinical Pharmacology|November 4, 2004
MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patientsIngrid Mai, Elke S Perloff, Steffen Bauer, et al.Clinical Pharmacology and Therapeutics|October 8, 2004
Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interactionIngrid Mai, Steffen Bauer, Elke S Perloff, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 18, 2021
Predictive In Vitro-In Vivo Extrapolation for Time Dependent Inhibition of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 Using Pooled Human Hepatocytes, Human Liver Microsomes, and a Simple Mechanistic Static ModelDiane Ramsden, Elke S Perloff, Andrea Whitcher-Johnstone, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2009
Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetineDavid M Stresser, Andrew K Mason, Elke S Perloff, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 7, 2016
Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by ClomethiazoleDavid M Stresser, Elke S Perloff, Andrew K Mason, et al.Journal of Clinical Psychopharmacology|January 17, 2007
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteersSheldon H Preskorn, David J Greenblatt, David Flockhart, et al.Journal of Clinical Pharmacology|January 25, 2006
Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrateDavid J Greenblatt, Lisa L von Moltke, Yan Luo, et al.Pageof 2